menu ☰
menu ˟

Roche to acquire Spark Therapeutics

25 Feb 2019
Roche will fully acquire Spark Therapeutics in a definitive merger agreement for a price of $114.50 per share.The total equity value of the deal is approximately $4.8 billion, inclusive of approximately $500 million of projected net cash expected at ...

Click here to view the full article which appeared in Opthalmology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.